drugset / Trial / NCT01806311

Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg

NCT01806311

Phase 1 Completed 36 enrolled HanAll BioPharma Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

Clinical trial to evalate the pharmacokinetic interactions and safety between single dose of amlodipine10mg and candesartan32mg and combiation dose amlodipine10mg with candesartan32mg in healthy male volunteers.

Timeline

Start
2012-12
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified 10 mg Oral
Comparator Candesartan Unknown 32 mg Oral

Indications